Related Experiment Videos
Complement activation and inhibition in myocardial ischemia and reperfusion injury
1Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0626.
Insights
The complement system significantly contributes to heart damage after reperfusion injury. Inhibiting this system, like with sCR1, shows potential for limiting this damage and improving treatment strategies.
Area of Science:
- Cardiovascular Biology
- Immunology
- Inflammation Research
Background:
- Myocardial ischemia and reperfusion trigger inflammatory responses similar to other tissues.
- The complement system is a key mediator in initiating and sustaining inflammatory processes.
Purpose of the Study:
- To investigate the role of complement activation in myocardial reperfusion injury.
- To explore the potential of complement inhibitors as a therapeutic strategy.
Main Methods:
- Review of existing literature on complement system activation and myocardial injury.
- Analysis of the mechanisms by which complement contributes to inflammation and cell damage.
Main Results:
- Complement activation promotes neutrophil adherence and activation, contributing to myocardial damage.
- The membrane attack complex directly causes endothelial and myocardial cell cytotoxicity.
- Complement inhibition, exemplified by sCR1, has demonstrated efficacy in limiting reperfusion injury.
Conclusions:
- The complement system plays a critical role in both the inflammatory response and direct tissue injury during myocardial reperfusion.
- Targeting the complement system offers a promising therapeutic avenue for mitigating reperfusion injury.
Abstract:
The myocardial inflammatory response that occurs as a result of ischemia and reperfusion is similar to that which occurs in other tissues. Activation of the complement system is an integral part of the initiation and maintenance of any inflammatory response. It and other immune system mediators participate in the promotion of neutrophil adherence to endothelium by modulating expression of various adhesion molecules. The complement system also serves an integral role in mediating neutrophil activation, the results of which have been documented in the setting of myocardial ischemia and reperfusion. Another aspect of the complement cascade, which has received little attention with respect to the heart, is the direct effects of complement activation such as endothelial and myocardial cell cytotoxicity mediated by the membrane attack complex. It is likely that this form of tissue injury contributes significantly to myocardial reperfusion injury. Given the numerous contributions of the complement system to the generation of the inflammatory response, and to directly-mediated tissue injury, selective inhibitors of the complement system have great potential to limit reperfusion injury. This has already been demonstrated for the complement inhibitor sCR1. In the future, it is likely that any therapeutic treatment of reperfusion injury will include modulation of the effects of complement activation.